Author:
ÖZDEMİR Özmert M.a.,SALDIRAY Savaş,ENLİ Yaşar,TÜRK Nilay,ERGİN Hacer
Reference26 articles.
1. 1. Patrinos ME. Neonatal apnea and the foundation of respiratory control. In: Martin RJ, Fanaroff AA, Walsh MC, eds. Fanaroff and Martin’s neonatal-perinatal medicine: diseases of the fetus and infant. 10th ed. Philadelphia: Elsevier Saunders 2015;1137-1146.
2. 2. Schmidt B, Roberts RS, Davis P, et al. Caffeine therapy for apnea of prematurity. N Engl J Med 2006;18;354:2112-2121. https://doi.org/10.1056/NEJMoa054065
3. 3. Park HW, Lim G, Chung SH, Chung S, Kim KS, Kim SN. Early caffeine use in very low birth weight infants and neonatal outcomes: a systematic review and meta-analysis. J Korean Med Sci 2015;30:1828-1835. https://doi.org/10.3346/jkms.2015.30.12.1828
4. 4. Sweet DG1, Carnielli V, Greisen G, et al. European Consensus Guidelines on the management of respiratory distress syndrome - 2016 update. Neonatology 2017;111:107-125.doi: 10.1159/000448985
5. 5. Cox C, Hashem NG, Tebbs J, Bookstaver PB, Iskersky V. Evaluation of caffeine and the development of necrotizing enterecolitis. J Neonatal Perinatal Med 2015;8:339-347. https://doi.org/10.3233/NPM-15814059